EUVIMEDEUVIMED entdecken
Crossref

In Silico Approach for Assessment of the Anti‐Tumor Potential of Cannabinoid Compounds by Targeting Glucose‐6‐Phosphate Dehydrogenase Enzyme

Cromwel Zemnou Tepap iD, Jaouad Anissi, Salim Bounou, Fernando Berton Zanchi

Chemistry & Biodiversity · 2024

DOI: 10.1002/cbdv.202401338 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Cromwel Zemnou Tepap und 3 weiteren Autor:innen. Beteiligte Einrichtung: EuroMed University of Fes (UEMF), Fes, Morocco. Hauptthemen laut MEDLINE: Antineoplastic Agents, Cannabinoids, Glucosephosphate Dehydrogenase, Molecular Docking Simulation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 65 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucose‐6‐phosphate dehydrogenase (G6PD) is a pentose phosphate pathway (PPP) enzyme that generates NADPH, which is required for cellular redox equilibrium and reductive biosynthesis. It has been demonstrated that abnormal G6PD activation promotes cancer cell proliferation and metastasis. To date, no G6PD inhibitor has passed clinical testing successfully enough to be launched as a medicine. As a result, in this investigation, cannabinoids were chosen to evaluate their anticancer potential by targeting G6PD. Molecular docking indicated that three molecules, Tetrahydrocannabinolic acid (THCA), Cannabichromenic acid (CBCA), and tetrahydrocannabivarin (THCV), have the highest binding affinities for G6PD of −8.61, −8.39, and 8.01 Kcal mol. ADMET analysis found that all of them were safe prospective drug candidates. Molecular dynamics (MD) simulation and MM‐PBSA analysis confirm the structural compactness and lower conformational variation of protein‐ligand complexes, thereby maintaining structural stability and rigidity. Thus, our in silico investigation exhibited all three cannabinoids as potential competitive inhibitors of G6PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsCannabinoidsGlucosephosphate DehydrogenaseMolecular Docking SimulationMolecular Dynamics SimulationHumansComputer SimulationDronabinolEnzyme InhibitorsMolecular Structure

Stichwörter der Autor:innen

Anti-tumourCannabinoidsGlucose-6-phosphate dehydrogenaseMolecular dockingMolecular dynamics simulations

Substanzen

Antineoplastic AgentscannabichromeneCannabinoidsDronabinolEnzyme InhibitorsGlucosephosphate Dehydrogenasedelta(1)-tetrahydrocannabinolic acid

Autor:innen und Institutionen

  • EuroMed University of Fes (UEMF), Fes, Morocco.
  • Laboratório de Bioinformática e Química Medicinal (LABIOQUIM), Fundação Oswaldo Cruz Rondônia,Porto Velho, RO, Brasil.

ORCID-Profile: Cromwel Zemnou Tepap

Zitieren

APA

Zemnou Tepap, C., Anissi, J., Bounou, S., & Berton Zanchi, F. (2024). In Silico Approach for Assessment of the Anti‐Tumor Potential of Cannabinoid Compounds by Targeting Glucose‐6‐Phosphate Dehydrogenase Enzyme. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401338

Vancouver

Zemnou Tepap C, Anissi J, Bounou S, Berton Zanchi F. In Silico Approach for Assessment of the Anti‐Tumor Potential of Cannabinoid Compounds by Targeting Glucose‐6‐Phosphate Dehydrogenase Enzyme. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202401338

BibTeX
@article{ZemnouTepap2024,
  author = {Zemnou Tepap, Cromwel and Anissi, Jaouad and Bounou, Salim and Berton Zanchi, Fernando},
  title = {In Silico Approach for Assessment of the Anti‐Tumor Potential of Cannabinoid Compounds by Targeting Glucose‐6‐Phosphate Dehydrogenase Enzyme},
  journal = {Chemistry & Biodiversity},
  year = {2024},
  doi = {10.1002/cbdv.202401338}
}
Kostenlos starten →